NCT07049250Completed
Evidence-Based Nursing for Psychological Resilience in Lung Cancer Chemotherapy Patients
Effect of Evidence-Based Nursing Intervention Under Quantitative Evaluation Strategy on Psychological Resilience and Illness Perception in Lung Cancer Patients Undergoing Chemotherapy
Source: ClinicalTrials.gov · Last updated 3 Jul 2025
Brief summary (registry, in English)
This study investigates the effect of an evidence-based nursing intervention, guided by a quantitative evaluation strategy, on psychological resilience and illness perception in lung cancer patients undergoing chemotherapy. Patients were randomized to receive either the specialized nursing intervention or routine nursing care, with outcomes assessed at baseline and 3 months post-intervention.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 142 (actual)
- First submitted
- 25 Jun 2025
- Start date
- 1 Mar 2024
- Primary completion date
- 1 Mar 2025
- Lead sponsor
- The First Hospital of Hebei Medical University
- Diseases
- Lung cancer, Childhood cancers
- NCT number
- NCT07049250
What you commit to
- Study type: Interventional
- Participants enrolled: 142
- From 1 Mar 2024 to the primary completion date, 1 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Contraindications to chemotherapy.
- Concurrent radiotherapy.
Other illness
- Pre-existing neurological disorders.
- Active infectious diseases.
Lab values
- Significant organ dysfunction (defined as Child-Pugh class B/C for liver function or eGFR \<30 mL/min/1.73m² for renal function).
Who the study is looking for
- Diagnosis of lung cancer confirmed according to the Chinese Quality Control Indicators for Standardized Diagnosis and Treatment of Primary Lung Cancer (2022) through both imaging and histopathological examination.
- TNM staging determined using the 8th edition AJCC/UICC classification system.
- Scheduled to receive chemotherapy with an expected survival exceeding one year.
- Demonstrated normal cognitive and communication abilities as assessed by standardized neuropsychological tests.
- Provided written informed consent prior to enrollment.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Hospital of Hebei Medical University Coordinator of this site? Confirm its status | Shijiazhuang | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.